Related Experiment Video
Updated: Aug 10, 2026

Generation of Organotypic Raft Cultures from Primary Human Keratinocytes
Published on: February 22, 2012
Pathogenesis and treatment of juvenile onset recurrent respiratory papillomatosis
G E Green1, N M Bauman, R J Smith
1Department of Otolaryngology-Head and Neck Surgery, University of Iowa, Iowa City, Iowa 52242, USA.
Abstract:
Juvenile onset recurrent respiratory papillomatosis is the most common cause of laryngeal tumors in children. This disease is caused by infection of the human papillomavirus, a virus whose complete genetic structure is now known. New, more directed agents show promise for improved control of papillomatosis in preliminary studies. Concurrently, there is an increasing awareness of methods to reduce surgical morbidity. At present, the role of preventive efforts including elective caesarian section remains uncertain.
Insights
Juvenile onset recurrent respiratory papillomatosis (JORRP), a common childhood laryngeal tumor caused by human papillomavirus, shows promise with new treatments. Research is exploring methods to reduce surgical complications and preventive strategies for JORRP.
Area of Science:
- Pediatric Oncology
- Virology
- Laryngology
Background:
- Juvenile onset recurrent respiratory papillomatosis (JORRP) is the most frequent laryngeal tumor in children.
- JORRP is caused by the human papillomavirus (HPV).
- The complete genetic structure of HPV is now understood.
Purpose of the Study:
- To review current understanding and emerging treatments for JORRP.
- To discuss strategies for reducing surgical morbidity associated with JORRP.
- To evaluate the uncertain role of preventive measures in JORRP management.
Main Methods:
- Review of preliminary studies on new therapeutic agents for JORRP.
- Analysis of evolving methods aimed at minimizing surgical complications.
- Assessment of the evidence regarding preventive interventions like elective Cesarean section.
Main Results:
- New, targeted agents demonstrate potential for enhanced JORRP control in initial research.
- There is growing awareness and investigation into techniques to decrease surgical morbidity.
- The efficacy of preventive measures, including elective Cesarean section, remains inconclusive.
Conclusions:
- Emerging therapies offer hope for improved management of JORRP.
- Reducing surgical complications is a key focus in current JORRP care.
- Further research is needed to clarify the role of preventive strategies in JORRP.
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cystic Fibrosis: Management
Sinus disease and chronic sinusitis...
Atypical Pneumonia
Smallpox
Poliomyelitis
Respiratory Syncytial Virus Disease
![Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60445.jpg&w=3840&q=50)
